Titel

Merkliste
1 Ergebnisse

Distinction between natural immunity from SARS-CoV-2 infect..:

Elyse M. Miller (11604050) ; Elle A. Law (11604053) ; Rawan Ajeen (11604056)...
https://figshare.com/articles/dataset/Distinction_between_natural_immunity_from_SARS-CoV-2_infection_and_acquired_immunity_from_vaccination_based_on_vaccination_status_ELISA_RBD_antibody_assay_and_Abbott_architect_SARS-CoV-2_IgG_assay_targeting_the_nucleocapsid_protein_/16868111. , 2021

Link: https://doi.org/10.1371/journal.pone.0259070.t001

RT Journal
T1 <Title>Distinction between natural immunity from SARS-CoV-2 infection and acquired immunity from vaccination, based on vaccination status, ELISA RBD antibody assay, and Abbott architect SARS-CoV-2 IgG assay targeting the nucleocapsid protein</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16868111&Exemplar=1&LAN=DE
				
A1 Elyse M. Miller (11604050)
A1 Elle A. Law (11604053)
A1 Rawan Ajeen (11604056)
A1 Jaclyn Karasik (11604059)
A1 Carmen Mendoza (6183287)
A1 Haley Abernathy (11604062)
A1 Haley Garrett (11604065)
A1 Elise King (3341091)
A1 John Wallace (3502763)
A1 Michael Zelek (11604068)
A1 Jessie K. Edwards (7481093)
A1 Khou Xiong (11604071)
A1 Cherese Beatty (11604074)
A1 Aaron T. Fleischauer (11604077)
A1 Emily J. Ciccone (9631415)
A1 Bonnie E. Shook-Sa (11079570)
A1 Allison E. Aiello (8563605)
A1 Ross M. Boyce (11010571)
YR 2021
K1 Medicine
K1 Biotechnology
K1 Immunology
K1 Cancer
K1 Science Policy
K1 Infectious Diseases
K1 Virology
K1 Environmental Sciences not elsewhere classified
K1 Biological Sciences not elsewhere classified
K1 least 24 months
K1 generate accurate estimates
K1 future analyses aim
K1 prior infection )
K1 observational study aimed
K1 anticipated study duration
K1 active infection )
K1 collected survey data
K1 based sampling design
K1 compare study data
K1 central north carolina
K1 285 total residents
K1 2 infection due
K1 study data
K1 north carolina
K1 2 infection
K1 critical data
K1 based settings
K1 wide metrics
K1 subclinical infections
K1 specific antibodies
K1 serum specimens
K1 risk factors
K1 policy decisions
K1 ongoing prospective
K1 nasal swabs
K1 monthly basis
K1 limited access
K1 june 23
K1 high proportion
K1 estimated 76
K1 enable collection
K1 2 virus
K1 153 participants
JF https://figshare.com/articles/dataset/Distinction_between_natural_immunity_from_SARS-CoV-2_infection_and_acquired_immunity_from_vaccination_based_on_vaccination_status_ELISA_RBD_antibody_assay_and_Abbott_architect_SARS-CoV-2_IgG_assay_targeting_the_nucleocapsid_protein_/16868111
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0259070.t001
DO https://doi.org/10.1371/journal.pone.0259070.t001
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)